The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for...
Pliant is slashing 45% of its workforce in a move to “minimise costs and preserv...
Whilst 2025 outlooks include cost impact from existing tariffs, companies have n...
The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya va...
As scientists explore treating genetic disorders before birth, the promise of fo...
The US HHS has launched a $500m initiative to accelerate the development of univ...
4D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced...
GSK said it remains confident it can absorb the financial impact of potential US...
Novartis has signed an agreement to acquire US-based Regulus Therapeutics and it...
J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FD...
Dimerix and Amicus Therapeutics have signed an agreement for the US commercialis...
Logistics providers can considerably ease the challenges of transporting essenti...
The post-traumatic stress disorder (PTSD) market is expected to grow at a high c...
Repare Therapeutics has entered into an out-licensing agreement with Canadian bi...
Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favo...
